Prostate cancer risk group is associated with other-cause mortality in men with localized prostate cancer

  • Rehana Rasul
  • Anne Golden
  • Michael A. Feuerstein Lenox Hill Hospital
Keywords: prostate cancer; SEER; mortality; other-cause mortality

Abstract

Introduction: Informed decision-making in localized prostate cancer must consider the natural history of the disease, risks of treatment, and the competing risks from other causes. Other-cause mortality has often been associated with comorbidity or treatment-related side effects. We aimed to examine the association between prostate cancer aggressiveness and other-cause mortality.

Methods: Using the Surveillance, Epidemiology, and End Results (SEER)18 registries, patients diagnosed with localized prostate cancer between 2004 and 2015 were identified. Patients were categorized into low-, intermediate- and high-risk groups. Vital status, death due to prostate cancer, and death due to other causes were based on death certificate information. Survival analyses were performed to assess the association between prostate cancer risk group and mortality while adjusting for demographic variables, year of diagnosis, and initial therapy.

Results: A total of 464 653 patients were identified with a median followup of 5.4 years. Cardiovascular disease was the most common cause of mortality during the study period. Compared to low-risk patients, intermediate- and high-risk patients had a higher risk of mortality from other cancers, cardiovascular disease, and other causes of death regardless of initial treatment. Men who underwent surgery as initial therapy had lower cumulative mortality rates compared to those with radiation as their initial therapy.

Conclusions: Intermediate- and high-risk prostate cancers are associated with higher risk of other-cause mortality. This appears to be independent of treatment type and may not be solely explained by comorbidity status. Further studies controlling for comorbidity and treatment burden should be explored.

Author Biographies

Rehana Rasul

Feinstein Institutes for Medical Research, Department of Occupational Medicine, Epidemiology and Prevention, Zucker School of Medicine at Hofstra/Northwell

Anne Golden

Feinstein Institutes for Medical Research, Department of Occupational Medicine, Epidemiology and Prevention, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York

Published
2020-05-12
How to Cite
Rasul, R., Golden, A., & Feuerstein, M. A. (2020). Prostate cancer risk group is associated with other-cause mortality in men with localized prostate cancer. Canadian Urological Association Journal, 14(10), E507-13. https://doi.org/10.5489/cuaj.6324
Section
Original Research